Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to diabetes mellitus and other diseases: part II

Author： Das >  

Publisher： Future Medicine

ISSN： 1758-4299

Source： Clinical Lipidology, Vol.8, Iss.4, 2013-08, pp. : 465-480

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to cancer: part I

By Das Undurti Narasimha  

Clinical Lipidology, Vol. 8, Iss. 4, 2013-08 ,pp. : 437-463

Future Medicine

Access to resources Recommend Favorite

Reappraisal of metallothionein: Clinical implications for patients with diabetes mellitus

By  

JOURNAL OF DIABETES, Vol. 10, Iss. 3, 2018-03 ,pp. : 213-231

John Wiley & Sons Inc

Access to resources Recommend Favorite

Periodontal Disease and Association with Diabetes Mellitus and Diabetes: Clinical Implications

By Genco Robert J.  

Journal of Dental Hygiene, Vol. 83, Iss. 4, 2009-0 ,pp. : 186-187

American Dental Hygienists' Association

Access to resources Recommend Favorite

Heart Failure in Diabetes mellitus: Clinical Features and Prognostic Implications

By  

Cardiology, Vol. 103, Iss. 3, 2005-04 ,pp. : 161-166

Karger

Access to resources Recommend Favorite

Lixisenatide, a novel GLP‐1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 16, Iss. 7, 2014-07 ,pp. : 588-601

John Wiley & Sons Inc

Access to resources Recommend Favorite